Medical Safety & Global Health
Open Access

Richa Sood

Biography

Dr. Richa Sood was born on 16th Sept., 1970 in Punjab, India. She completed her Ph.D. in Veterinary Medicine and is working as scientist at High Security Animal Disease Laboratory which is a Biosafety level 3+ laboratory and Biosafety level 4 Animal Bio-containment facility and an OIE reference facility for Avian Influenza, at Bhopal, India since December 1999. She is In-charge Animal Facility and Assistant Biosafety Officer since last 11 years. She is a member of International Veterinary Biosafety Workgroup and a core member of the Society for Biosafety in India. Besides her role in Animal Biosafety, she has developed monoclonal antibodies used as diagnostics. Recently she has in initiating work on antivirals against avian influenza. In the fore-front of antiviral research, she has established contacts with International Consortium on Antivirals (ICAV) and has presented her results in ICAV sponsored conference at France in 2009.

Research Interest

Biosafety: As Assistant Biosafety Officer of BSL3+ facility and also Officer in-charge of the ABSL4 facility of HSADL, I ensure the use of biosafety concept as a scientific method for prevention of spread of infection through man, material and place or cross contamination within the laboratory and ensure that during experimentation issues related to Biosafety and animal ethics are followed. I have been a resource person as well as conducted trainings in bio-containment and biosafety and Avian Influenza diagnosis to various national and International trainees.
Research area: I have been an associate in production of monoclonal antibodies for its use in development of diagnostics against expressed proteins of Bovine Viral Diarrhoea Virus, Bovine Immunodeficiency Virus and Avian Influenza Virus and development of diagnostic tests against these viruses using monoclonal and recombinant antibodies. Recently I have been exploring the area of Ethno-veterinary Medicine and synthetic antivirals wherein they are being screened for identification of antiviral properties against Avian Influenza Virus and identification of antiviral resistance against the prevailing Influenza viruses.

Relevant Topics